| Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease PJ Eddowes, M Sasso, M Allison, E Tsochatzis, QM Anstee, D Sheridan, ... Gastroenterology 156 (6), 1717-1730, 2019 | 1044 | 2019 |
| Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers IN Guha, J Parkes, P Roderick, D Chattopadhyay, R Cross, S Harris, ... Hepatology 47 (2), 455-460, 2008 | 931 | 2008 |
| FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation … PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ... The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020 | 572 | 2020 |
| Performance of serum marker panels for liver fibrosis in chronic hepatitis C J Parkes, IN Guha, P Roderick, W Rosenberg Journal of hepatology 44 (3), 462-474, 2006 | 308 | 2006 |
| Prediction, prevention and management of postresection liver failure JS Hammond, IN Guha, IJ Beckingham, DN Lobo Journal of British Surgery 98 (9), 1188-1200, 2011 | 241 | 2011 |
| aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ... Journal of hepatology 73 (6), 1368-1378, 2020 | 226 | 2020 |
| ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis SJ Daniels, DJ Leeming, M Eslam, AM Hashem, MJ Nielsen, A Krag, ... Hepatology 69 (3), 1075-1086, 2019 | 225 | 2019 |
| Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C J Parkes, IN Guha, P Roderick, S Harris, R Cross, MM Manos, W Irving, ... Journal of viral hepatitis 18 (1), 23-31, 2011 | 214 | 2011 |
| Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus S Knapp, U Warshow, D Hegazy, L Brackenbury, IN Guha, A Fowell, ... Hepatology 51 (4), 1168-1175, 2010 | 207 | 2010 |
| Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review R Harris, DJ Harman, TR Card, GP Aithal, IN Guha The lancet Gastroenterology & hepatology 2 (4), 288-297, 2017 | 195 | 2017 |
| Screening for liver fibrosis in the general population: a call for action P Ginès, I Graupera, F Lammert, P Angeli, L Caballeria, A Krag, IN Guha, ... The lancet Gastroenterology & hepatology 1 (3), 256-260, 2016 | 184 | 2016 |
| Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease IN Guha, J Parkes, PR Roderick, S Harris, WM Rosenberg Gut 55 (11), 1650-1660, 2006 | 180 | 2006 |
| Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases P Ginès, L Castera, F Lammert, I Graupera, M Serra‐Burriel, AM Allen, ... Hepatology 75 (1), 219-228, 2022 | 167 | 2022 |
| Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease S Tanwar, PM Trembling, IN Guha, J Parkes, P Kaye, AD Burt, SD Ryder, ... Hepatology 57 (1), 103-111, 2013 | 152 | 2013 |
| A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histological factors CL Hoad, N Palaniyappan, P Kaye, Y Chernova, MW James, C Costigan, ... NMR in Biomedicine 28 (6), 706-714, 2015 | 146 | 2015 |
| Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population I Graupera, M Thiele, M Serra-Burriel, L Caballeria, D Roulot, GLH Wong, ... Clinical Gastroenterology and Hepatology 20 (11), 2567-2576. e6, 2022 | 140 | 2022 |
| Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia M Serra-Burriel, I Graupera, P Torán, M Thiele, D Roulot, VWS Wong, ... Journal of hepatology 71 (6), 1141-1151, 2019 | 138 | 2019 |
| Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging N Palaniyappan, E Cox, C Bradley, R Scott, A Austin, R O’Neill, G Ramjas, ... Journal of hepatology 65 (6), 1131-1139, 2016 | 128 | 2016 |
| Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography DJ Harman, SD Ryder, MW James, M Jelpke, DS Ottey, EA Wilkes, ... BMJ open 5 (4), e007516, 2015 | 120 | 2015 |
| Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans J Pritchett, E Harvey, V Athwal, A Berry, C Rowe, F Oakley, A Moles, ... Hepatology 56 (3), 1108-1116, 2012 | 115 | 2012 |
